Hims & Hers Health, Inc. logo

Hims & Hers Health, Inc. (HIMS)

Market Closed
17 Jul, 20:00
NYSE NYSE
$
32. 84
-0.84
-2.4941%
$
7.51B Market Cap
- P/E Ratio
- Div Yield
9.15M Volume
-0.14 Eps
$ 33.68
Previous Close
Add Transaction
Day Range
31.91 34.04
Year Range
13.74 70.43
Want to track HIMS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

HIMS closed today lower at $32.84, a decrease of -2.4941% from yesterday's close, completing a monthly increase of 25.3914% or $6.65. Over the past 12 months, HIMS stock lost -0.4848%.
HIMS is not paying dividends to its shareholders.
The last earnings report, released on May 04, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0039%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NYSE (USD).

HIMS Chart

People also search for

TKR
Timken Co.
$ 137.78
+0.0654%
UHS
Universal Health Services, Inc.
$ 151.16
-1.5501%
Glaukos Corporation
$ 156.83
+0.9267%
TTC
The Toro Company
$ 94.42
-1.5535%
Bio-Rad Laboratories, Inc.
$ 324.98
+5.0457%
Hims & Hers Health, Inc. (HIMS) Outpaces Stock Market Gains: What You Should Know

Hims & Hers Health, Inc. (HIMS) Outpaces Stock Market Gains: What You Should Know

Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $35.15, moving +2.24% from the previous trading session.

Zacks | 3 days ago
Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now?

Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now?

Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 4 days ago
Hims & Hers Health: The Market Still Doesn't Get It

Hims & Hers Health: The Market Still Doesn't Get It

FDA staff challenged seven compounded peptides, but Hims & Hers continues expanding internationally and strengthening its core healthcare platform beyond longevity therapies. The $400 million JPMorgan receivables facility improves financial flexibility, supporting GLP-1 expansion without relying on dilutive equity financing. The $1.15 billion Eucalyptus acquisition adds 850,000 customers and approximately $450 million of ARR across eight international markets.

Seekingalpha | 1 week ago

Hims & Hers Health, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
TMB
Timothy M. Bidwell Hazlett, BURT & WATSON Inc.
1,877 $89,273.45 $69,317.61 -$19,955.84 -22.35%
CE
Curtis Ellergodt Rothschild Investment LLC
254 $8,055.02 $9,380.22 $1,325.2 16.45%
Means Investment Company
Means Investment Company Means Investment Company Inc.
12,667 $288,092.22 $467,792.31 $179,700.09 62.38%
JD
Jim Dushek HARBOUR INVESTMENTS Inc.
10,014 $381,325.72 $367,113.24 -$14,212.48 -3.73%
Farallon Capital
Farallon Capital Farallon Capital Management LLC
10,000 $567,200 $370,000 -$197,200 -34.77%

Hims & Hers Health, Inc. Analysts

Name Quantity Cost Value Profit ($) Gain (%)
Glen Santangelo
Glen Santangelo Barclays
209.03 $7,311.6 $7,107.02 -$204.58 -2.8%
Maria Ripps
Maria Ripps Canaccord Genuity
16,017.71 $601,785.3 $595,378.22 -$6,407.08 -1.06%

Hims & Hers Health, Inc. (HIMS) FAQ

What is the stock price today?

The current price is $32.84.

On which exchange is it traded?

Hims & Hers Health, Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is HIMS.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 7.51B.

Has Hims & Hers Health, Inc. ever had a stock split?

No, there has never been a stock split.

Hims & Hers Health, Inc. Profile

Health Care Providers & Services Industry
Healthcare Sector
Andrew Dudum CEO
NYSE Exchange
433000106 CUSIP
US Country
2,442 Employees
- Last Dividend
- Last Split
13 Sep 2019 IPO Date

Overview

Hims & Hers Health, Inc., based in San Francisco, California, operates as a telehealth platform connecting consumers with licensed healthcare professionals across the United States, the United Kingdom, and other international locations. The company leverages its websites and mobile application to offer a variety of carefully selected health and wellness products and services, both on prescription and over-the-counter basis. Its business model focuses on providing convenient access to ongoing healthcare services, including prescription medication refills and consultations with healthcare providers, as well as a wide range of wellness products through direct sales and wholesale partnerships.

Products and Services

  • Prescription Medication: Customers can receive prescription medication on a recurring basis, ensuring continuous care and support from healthcare providers.
  • Over-The-Counter Drug and Device Products: Offers a selection of non-prescription products, including cosmetics and supplements, focused on general wellness, sexual health, skincare, and hair care.
  • Curated Non-Prescription Products: This includes:
    • Wellness Specialty: Products like melatonin for sleep and biotin for wellness.
    • Skincare Specialty: A range of skincare products including moisturizers, creams, sunscreen, serum, face oil, and face wash.
    • Sexual Health and Wellness Specialty: Items such as condoms, climax delay spray and wipes, vibrators, and lubricants.
    • Hair Care Specialty: Products like shampoos, conditioners, scalp scrubs, and topical treatments, including minoxidil.
  • Medical Consultation and Post-Consultation Support Services: Offers comprehensive consultation services and follow-up support to ensure effective healthcare management.
  • Health and Wellness Products through Wholesale Partners: Besides direct sales, the company expands its reach by distributing health and wellness products through trusted wholesale partners.

Contact Information

Address: 2269 Chestnut Street
Phone: 415 851 0195